165 related articles for article (PubMed ID: 34366675)
1. Glypican-1 Overexpression in Different Types of Breast Cancers.
Alshammari FOFO; Al-Saraireh YM; Youssef AMM; Al-Sarayra YM; Alrawashdeh HM
Onco Targets Ther; 2021; 14():4309-4318. PubMed ID: 34366675
[TBL] [Abstract][Full Text] [Related]
2. Screening of Glypican-6 Expression in Benign, Primary and Metastatic Colon Cancers.
Al-Saraireh YM; Alshammari FO; Youssef AM; Al-Sarayreh S; Al-Sarayra YM; Aborajooh E; Al-Shuneigat J; Alrawashdeh HM
Clin Med Insights Oncol; 2021; 15():11795549211036419. PubMed ID: 34393539
[TBL] [Abstract][Full Text] [Related]
3. Glypican-3 Differentiates Intraductal Carcinoma and Paget's Disease from Other Types of Breast Cancer.
Alshammari FO; Satari AO; Aljabali AS; Al-Mahdy YS; Alabdallat YJ; Al-Sarayra YM; Alkhojah MA; Alwardat ARM; Haddad M; Al-Sarayreh SA; Al-Saraireh YM
Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676710
[No Abstract] [Full Text] [Related]
4. Prognostic impact of the glypican family of heparan sulfate proteoglycans on the survival of breast cancer patients.
Grillo PK; Győrffy B; Götte M
J Cancer Res Clin Oncol; 2021 Jul; 147(7):1937-1955. PubMed ID: 33742285
[TBL] [Abstract][Full Text] [Related]
5. Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells.
Matsuda K; Maruyama H; Guo F; Kleeff J; Itakura J; Matsumoto Y; Lander AD; Korc M
Cancer Res; 2001 Jul; 61(14):5562-9. PubMed ID: 11454708
[TBL] [Abstract][Full Text] [Related]
6. Specific genes involved in synthesis and editing of heparan sulfate proteoglycans show altered expression patterns in breast cancer.
Fernández-Vega I; García O; Crespo A; Castañón S; Menéndez P; Astudillo A; Quirós LM
BMC Cancer; 2013 Jan; 13():24. PubMed ID: 23327652
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of glypican 3 in endometrial carcinoma and correlation with prognostic parameters.
Hakim SA; Raboh NM
Int J Clin Exp Pathol; 2015; 8(10):13225-32. PubMed ID: 26722522
[TBL] [Abstract][Full Text] [Related]
8. The Heparan Sulfate Proteoglycan Glypican-6 Is Upregulated in the Failing Heart, and Regulates Cardiomyocyte Growth through ERK1/2 Signaling.
Melleby AO; Strand ME; Romaine A; Herum KM; Skrbic B; Dahl CP; Sjaastad I; Fiane AE; Filmus J; Christensen G; Lunde IG
PLoS One; 2016; 11(10):e0165079. PubMed ID: 27768722
[TBL] [Abstract][Full Text] [Related]
9. Glypican-6, a new member of the glypican family of cell surface heparan sulfate proteoglycans.
Veugelers M; De Cat B; Ceulemans H; Bruystens AM; Coomans C; Dürr J; Vermeesch J; Marynen P; David G
J Biol Chem; 1999 Sep; 274(38):26968-77. PubMed ID: 10480909
[TBL] [Abstract][Full Text] [Related]
10. Glypican-3 expression is markedly decreased in human gastric cancer but not in esophageal cancer.
Zhu Z; Friess H; Kleeff J; Wang L; Wirtz M; Zimmermann A; Korc M; Büchler MW
Am J Surg; 2002 Jul; 184(1):78-83. PubMed ID: 12135726
[TBL] [Abstract][Full Text] [Related]
11. Glypican 3 Overexpression across a Broad Spectrum of Tumor Types Discovered with Functional Genomic mRNA Profiling of a Large Cancer Database.
Moek KL; Fehrmann RSN; van der Vegt B; de Vries EGE; de Groot DJA
Am J Pathol; 2018 Sep; 188(9):1973-1981. PubMed ID: 29935166
[TBL] [Abstract][Full Text] [Related]
12. Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders.
Zhu ZW; Friess H; Wang L; Abou-Shady M; Zimmermann A; Lander AD; Korc M; Kleeff J; Büchler MW
Gut; 2001 Apr; 48(4):558-64. PubMed ID: 11247902
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms underlying preferential assembly of heparan sulfate on glypican-1.
Chen RL; Lander AD
J Biol Chem; 2001 Mar; 276(10):7507-17. PubMed ID: 11106655
[TBL] [Abstract][Full Text] [Related]
14. Heparan sulfate expression in polarized epithelial cells: the apical sorting of glypican (GPI-anchored proteoglycan) is inversely related to its heparan sulfate content.
Mertens G; Van der Schueren B; van den Berghe H; David G
J Cell Biol; 1996 Feb; 132(3):487-97. PubMed ID: 8636224
[TBL] [Abstract][Full Text] [Related]
15. Syndecan-1 and syndecan-4 are overexpressed in an estrogen receptor-negative, highly proliferative breast carcinoma subtype.
Baba F; Swartz K; van Buren R; Eickhoff J; Zhang Y; Wolberg W; Friedl A
Breast Cancer Res Treat; 2006 Jul; 98(1):91-8. PubMed ID: 16636895
[TBL] [Abstract][Full Text] [Related]
16. Characterization of glypican-5 and chromosomal localization of human GPC5, a new member of the glypican gene family.
Veugelers M; Vermeesch J; Reekmans G; Steinfeld R; Marynen P; David G
Genomics; 1997 Feb; 40(1):24-30. PubMed ID: 9070915
[TBL] [Abstract][Full Text] [Related]
17. Glypican-3: A New Target for Diagnosis and Treatment of Hepatocellular Carcinoma.
Guo M; Zhang H; Zheng J; Liu Y
J Cancer; 2020; 11(8):2008-2021. PubMed ID: 32127929
[TBL] [Abstract][Full Text] [Related]
18. Discovery and diagnostic value of a novel oncofetal protein: glypican 3.
Wang SK; Zynger DL; Hes O; Yang XJ
Adv Anat Pathol; 2014 Nov; 21(6):450-60. PubMed ID: 25299314
[TBL] [Abstract][Full Text] [Related]
19. K-glypican: a novel GPI-anchored heparan sulfate proteoglycan that is highly expressed in developing brain and kidney.
Watanabe K; Yamada H; Yamaguchi Y
J Cell Biol; 1995 Sep; 130(5):1207-18. PubMed ID: 7657705
[TBL] [Abstract][Full Text] [Related]
20. The glypican family of heparan sulfate proteoglycans: major cell-surface proteoglycans of the developing nervous system.
Lander AD; Stipp CS; Ivins JK
Perspect Dev Neurobiol; 1996; 3(4):347-58. PubMed ID: 9117265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
